Emcure launches Galact supplement for breastfeeding mothers in over-the-counter market
Written by: Planify
Published: 13 March 2024
Updated: 13 March 2024
1 min read
Emcure Pharmaceuticals has announced its foray into the over-the-counter (OTC) market with the launch of its flagship product, Galact. According to a press release, Galact, a lactation supplement designed to enhance breast milk production, has been prescribed by healthcare professionals for over two decades and will now be available as an OTC offering.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
Address
MiQB, Plot 23, Sector 18, Maruti Industrial Development Area, Opposite VLCC corporate office, Gurugram, Haryana 122015
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
